BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

GlySure 

Units 4-6 The Quadrant
Abingdon Science Park
Abingdon  Oxfordshire  OX14 3YS  United Kingdom
Phone: 44-0-1235-462-870 Fax: n/a


SEARCH JOBS




Industry
Medical Device






 Company News
GlySure Presents Successful Medical ICU Study Results At ESICM 9/29/2014 9:27:04 AM
GlySure CEO To Present CE Mark Trial Results At OneMedForum 2014 1/7/2014 6:32:21 AM
GlySure Completes Enrollment in Cardiac Intensive Care CBGM CE Mark Trial 10/30/2013 11:00:19 AM
GlySure Wins 2013 Small Business of the Year and New Product of the Year 10/1/2013 8:51:44 AM
GlySure Appoints Justine McQuillan as European Director of Clinical Affairs 9/25/2013 6:28:45 AM
Study Demonstrates GlySure 's Ability to Accurately Measure Blood Glucose Levels in the ICU 8/28/2013 11:03:53 AM
GlySure Appoints William Moffitt as Executive Chairman 6/26/2013 6:23:31 AM
GlySure CEO to Present ICU Trial Results at Spring Medtech Industry Conferences 3/26/2013 9:45:08 AM
GlySure Earns ISO 13485 Certification 3/5/2013 11:58:30 AM
GlySure Completes Series C Second Closing for a Total of $13.6 Million 11/28/2012 6:57:52 AM
12